NRC Health Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
NRC Health (NRC) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2026-03-05
- NRC Health unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2025 was $0.00.
- NRC Health unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $0.00.
- NRC Health unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $0.00.
- NRC Health unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2019 was $300.00K, a 0.00% change from fiscal 2018.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2019-12-31 | $300.00K 10-K · filed 2021-03-05 |
| 2018-12-31 | $300.00K 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |